Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4042509, 10 pages
https://doi.org/10.1155/2017/4042509
Research Article

Mitochondria Associated MicroRNA Expression Profiling of Heart Failure

1Institute of Molecular Medicine, Peking University, Beijing, China
2Laboratory Animal Center, Peking University, Beijing, China
3Division of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China

Correspondence should be addressed to Huiqing Cao

Received 28 April 2017; Revised 27 July 2017; Accepted 13 August 2017; Published 24 September 2017

Academic Editor: Tianxiao Huan

Copyright © 2017 Xiaoxia Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. Gustafsson and R. A. Gottlieb, “Heart mitochondria: gates of life and death,” Cardiovascular Research, vol. 77, no. 2, pp. 334–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Bayeva, M. Gheorghiade, and H. Ardehali, “Mitochondria as a therapeutic target in heart failure,” Journal of the American College of Cardiology, vol. 61, no. 6, pp. 599–610, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Cheng, R. Ji, J. Yue et al., “MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a pole in cardiac hypertrophy?” The American Journal of Pathology, vol. 170, no. 6, pp. 1831–1840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Greco, P. Fasanaro, S. Castelvecchio et al., “MicroRNA dysregulation in diabetic ischemic heart failure patients,” Diabetes, vol. 61, no. 6, pp. 1633–1641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. L. Montgomery, T. G. Hullinger, H. M. Semus et al., “Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure,” Circulation, vol. 124, no. 14, pp. 1537–1547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Su, J. Wang, C. Wang et al., “MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis,” Cell Death and Differentiation, vol. 22, no. 6, pp. 986–999, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zhou, J. Gao, X. Zhang et al., “microRNA-340-5p functions downstream of cardiotrophin-1 to regulate cardiac eccentric hypertrophy and heart failure via target gene dystrophin,” International Heart Journal, vol. 56, no. 4, pp. 454–458, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Li, J. Fan, Z. Yin, F. Wang, C. Chen, and D. W. Wang, “Identification of cardiac-related circulating microRNA profile in human chronic heart failure,” Oncotarget, vol. 7, no. 1, pp. 33–45, 2016. View at Publisher · View at Google Scholar
  10. H.-W. Hwang, E. A. Wentzel, and J. T. Mendell, “A hexanucleotide element directs microRNA nuclear import,” Science, vol. 315, no. 5808, pp. 97–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Bandiera, S. Rüberg, M. Girard et al., “Nuclear outsourcing of RNA interference components to human mitochondria,” PLoS ONE, vol. 6, no. 6, Article ID e20746, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Geiger and L. T. Dalgaard, “Interplay of mitochondrial metabolism and microRNAs,” Cellular and Molecular Life Sciences, vol. 74, no. 4, pp. 631–646, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Zhang, X. Zuo, B. Yang et al., “MicroRNA directly enhances mitochondrial translation during muscle differentiation,” Cell, vol. 158, no. 3, pp. 607–619, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Das, M. Ferlito, O. A. Kent et al., “Nuclear miRNA regulates the mitochondrial genome in the heart,” Circulation Research, vol. 110, no. 12, pp. 1596–1603, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Carrer, N. Liu, C. E. Grueter et al., “Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 38, pp. 15330–15335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Wang, J. Li, H. Chi et al., “MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells,” Journal of Cellular and Molecular Medicine, vol. 19, no. 9, pp. 2084–2097, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bandiera, R. Matégot, M. Girard, J. Demongeot, and A. Henrion-Caude, “MitomiRs delineating the intracellular localization of microRNAs at mitochondria,” Free Radical Biology and Medicine, vol. 64, pp. 12–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Srinivasan and S. Das, “Mitochondrial miRNA (MitomiR): A new player in cardiovascular health,” Canadian Journal of Physiology and Pharmacology, vol. 93, no. 10, pp. 855–861, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Jagannathan, D. Thapa, C. E. Nichols et al., “Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart,” Circulation: Cardiovascular Genetics, vol. 8, no. 6, pp. 785–802, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. K. Kumarapeli, H. Su, W. Huang et al., “αb-crystallin suppresses pressure overload cardiac hypertrophy,” Circulation Research, vol. 103, no. 12, pp. 1473–1482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni et al., “DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions,” Nucleic Acids Research, vol. 43, no. 1, pp. D153–D159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. I. S. Vlachos, K. Zagganas, M. D. Paraskevopoulou et al., “DIANA-miRPath v3.0: deciphering microRNA function with experimental support,” Nucleic Acids Research, vol. 43, no. W1, pp. W460–W466, 2015. View at Publisher · View at Google Scholar
  23. S. Hein, S. Kostin, A. Heling, Y. Maeno, and J. Schaper, “The role of the cytoskeleton in heart failure,” Cardiovascular Research, vol. 45, no. 2, pp. 273–278, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. H. P. J. Buermans, E. M. Redout, A. E. Schiel et al., “Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure,” Physiological Genomics, vol. 21, pp. 314–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. D.-F. Dai, E. J. Hsieh, T. Chen et al., “Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides,” Circulation: Heart Failure, vol. 6, no. 5, pp. 1067–1076, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. R. D. Bagnall, T. Tsoutsman, R. E. Shephard, W. Ritchie, and C. Semsarian, “Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure,” PLoS ONE, vol. 7, no. 9, Article ID e44744, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Zhu, H. Wang, F. Liu et al., “Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy,” Journal of Cellular and Molecular Medicine, vol. 17, no. 9, pp. 1173–1187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. V. N. Prasad, M. K. Gupta, Z.-H. Duan et al., “A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks,” PLoS ONE, vol. 12, no. 3, Article ID e0170456, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Liu, H. Meng, C. Jiang, S. Yang, F. Cui, and P. Yang, “Differential microRNA expression and regulation in the rat model of post-infarction heart failure,” PLoS ONE, vol. 11, no. 8, Article ID e0160920, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Bianchessi, I. Badi, M. Bertolotti et al., “The mitochondrial lncRNA ASncmtRNA-2 is induced in aging and replicative senescence in Endothelial Cells,” Journal of Molecular and Cellular Cardiology, vol. 81, pp. 62–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Sripada, K. Singh, A. V. Lipatova et al., “hsa-miR-4485 regulates mitochondrial functions and inhibits the tumorigenicity of breast cancer cells,” Journal of Molecular Medicine, vol. 95, no. 6, pp. 641–651, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Lemieux, A. L. Bulteau, B. Friguet, J.-C. Tardif, and P. U. Blier, “Dietary fatty acids and oxidative stress in the heart mitochondria,” Mitochondrion, vol. 11, no. 1, pp. 97–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. M. Den Ruijter, A. O. Verkerk, C. A. Schumacher et al., “A diet rich in unsaturated fatty acids prevents progression toward heart failure in a rabbit model of pressure and volume overload,” Circulation: Heart Failure, vol. 5, no. 3, pp. 376–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. P. Halestrap, “The regulation of the oxidation of fatty acids and other substrates in rat heart mitochondria by changes in the matrix volume induced by osmotic strength, valinomycin and Ca2+,” The Biochemical Journal, vol. 244, no. 1, pp. 159–164, 1987. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Forini, G. Nicolini, and G. Iervasi, “Mitochondria as key targets of cardioprotection in cardiac ischemic disease: Role of thyroid hormone triiodothyronine,” International Journal of Molecular Sciences, vol. 16, no. 3, pp. 6312–6336, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhang and D. P. Del Re, “A growing role for the Hippo signaling pathway in the heart,” Journal of Molecular Medicine, vol. 95, no. 5, pp. 465–472, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Aoi, Y. Naito, K. Mizushima et al., “The microRNA miR-696 regulates PGC-1α in mouse skeletal muscle in response to physical activity,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 4, pp. E799–E806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Wen, H. Zhang, C. Bao et al., “Resistin Increases Ectopic Deposition of Lipids Through miR-696 in C2C12 Cells,” Biochemical Genetics, vol. 53, no. 4-6, pp. 63–71, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Fang, P. Li, W. Jia, T. Jiang, Z. Wang, and Y. Xiang, “miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α,” International Journal of Molecular Medicine, vol. 38, no. 3, pp. 845–852, 2016. View at Publisher · View at Google Scholar
  40. Y. Qi, Z. Xu, Q. Zhu et al., “Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance,” Diabetes, vol. 62, no. 11, pp. 3887–3900, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. M. Spitler, J. M. Ponce, G. Y. Oudit, D. D. Hall, and C. E. Grueter, “Cardiac med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 312, no. 4, pp. H768–H780, 2017. View at Publisher · View at Google Scholar · View at Scopus
  42. C. K. L. Phoon, R. P. Ji, O. Aristizábal et al., “Embryonic heart failure in NFATc1-/- mice novel: Mechanistic insights from in utero ultrasound biomicroscopy,” Circulation Research, vol. 95, no. 1, pp. 92–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Guo, S. Schafer, M. L. Greaser et al., “RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing,” Nature Medicine, vol. 18, no. 5, pp. 766–773, 2012. View at Publisher · View at Google Scholar
  44. J. J. L. Wong, W. Ritchie, D. Gao et al., “Identification of nuclear-enriched miRNAs during mouse granulopoiesis,” Journal of Hematology and Oncology, vol. 7, no. 1, article 42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Yu, Q. Geng, Q. Pan et al., “MiR-690, a Runx2-targeted miRNA, regulates osteogenic differentiation of C2C12 myogenic progenitor cells by targeting NF-kappaB p65,” Cell and Bioscience, vol. 6, no. 1, article 10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Chang, H. Qi, Y. Xiao et al., “Integrated analysis of noncoding RNAs and mRNAs reveals their potential roles in the biological activities of the growth hormone receptor,” Growth Hormone and IGF Research, vol. 29, pp. 11–20, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Tang, L. Muniappan, G. Tang, and S. Özcan, “Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription,” RNA, vol. 15, no. 2, pp. 287–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Chavali, S. C. Tyagi, and P. K. Mishra, “Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts,” Cell Biochemistry and Biophysics, vol. 68, no. 1, pp. 25–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Zheng, K.-L. Chen, X.-M. Zheng, H.-X. Li, and G.-L. Wang, “Identification and bioinformatics analysis of microRNAs associated with stress and immune response in serum of heat-stressed and normal Holstein cows,” Cell Stress and Chaperones, vol. 19, no. 6, pp. 973–981, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. A. J. Tijsen, Y. M. Pinto, and E. E. Creemers, “Non-cardiomyocyte microRNAs in heart failure,” Cardiovascular Research, vol. 93, no. 4, pp. 573–582, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Yamagami, T. Oka, Q. Wang et al., “Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 309, no. 3, pp. H512–H522, 2015. View at Publisher · View at Google Scholar · View at Scopus